ARBUTUS BIOPHARMA CORP (ABUS)

CA03879J1003 - Common Stock

2.73  +0.01 (+0.37%)

After market: 2.73 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
18.14M39.02M10.99M6.91M6.01M
Operating Expenses
96.24M104.48M84.51M64.66M77.18M
Research and Development
73.70M84.41M65.50M47.48M57.60M
Selling, General, and Administrative Expenses
22.48M17.83M17.14M14.72M17.73M
Operating Income
-78.10M-65.46M-73.52M-57.75M-71.17M
Interest Income/Expense
5.25M440.00K-2.73M-5.94M-22.48M
Non Recurring Items
N/AN/A0.00-60.00K-72.73M
Income Before Taxes
-72.85M-65.01M-76.25M-63.75M-166.38M
Income Tax
0.004.44MN/A0.00-12.66M
Net Income
-72.85M-69.46M-88.39M-75.87M-164.87M
EBITDA
-76.70M-64.03M-71.77M-55.77M-69.14M
 
Per Share Data
EPS Diluted Total Ops
-0.44-0.46-0.83-1.00-2.89
Non GAAP EPS
-0.44-0.47-0.83-1.00-2.40
 
Statistics
Profit Margin
-401.57%-178.01%-804.28%-1097.97%-2743.26%
Operating Profit Margin
-430.53%-167.76%-668.97%-835.75%-1184.19%

All data in USD

Charts